Comparison of The Percentage of The Risk of Death in TBC Comorbid Patients with Other Comorbids in Pati District

Randi Eka Istananta; Teguh Budiharjo; Surati Surati

doi:10.31983/jlm.v5i2.9829

Comparison of The Percentage of The Risk of Death in TBC Comorbid Patients with Other Comorbids in Pati District

Randi Eka Istananta, Teguh Budiharjo, Surati Surati

Abstract

Corona Virus Disease 2019 (COVID-19) is a disease that has never previously been found in humans and is a new type of disease. The virus that causes COVID-19 is called Sars-CoV-2. It was found that patients experienced increased mortality due to COVID-19 because they had comorbid diseases. COVID-19 patients who have one comorbid disease are at risk of death up to 6.5 times higher than COVID-19 patients without comorbidities. Pulmonary TB is a comorbidity that can make a person more susceptible to contracting COVID-19 with severe symptoms. Apart from attacking the lungs, COVID-19 also damages the lungs. Damaged lungs prevent the body's organs from getting enough oxygen, which can trigger organ damage that can cause death. The aim of this study was to compare the percentage risk of death in COVID-19 patients who had comorbid TB disease with COVID-19 patients who had comorbid kidney disease and DM in the Pati area, Central Java. This research can be a reference for data regarding the percentage risk of death in COVID-19 patients with comorbidities. This research uses a descriptive, observational research design. The samples in this study were COVID-19 sufferers who had comorbid TB, comorbid kidney disease and comorbid DM. The sample population during the period January to December 2021 was 998. The sample was determined using the Slovin formula with a total of 135 samples with a sampling quota taken. Results Comorbid TB has a percentage risk of death of 40%, comorbid kidney has a percentage risk of death of 33.3%, and comorbid DM has a percentage risk of death of 6.8%. Comorbid TB is a comorbid that has the highest percentage risk of death, so intensive care is important for sufferers.

Keywords

COVID-19 ; Comorbidities ; TB ; Risk of Death

Full Text:

PDF

References

Aggarwal AN, Agarwal R, Dhooria S, Prasad KT, Sehgal IS, Muthu V. (2021). Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis. Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. https://doi.org/10.1371/journal.pone.0259006

Alkautsar, A. (2021). Hubungan Penyakit Komorbid Dengan Tingkat Keparahan Pasien Covid-19. Jurnal Medika Hutama, 3(01 Oktober), 1488-1494. Retrieved from https://jurnalmedikahutama.com/index.php/JMH/article/view/302

Cahyaningtyas, T., Maruti, E., & Yunianto, T. (2021). Penyuluhan Tbc Dan Covid-19 Pada Ibu Pkk Desa Teguhan Kecamatan Jiwan Kabupaten Madiun. Indonesian JournalOf Community Service. http://ijocs.rcipublisher.org/index.php/ijocs/article/view/116

Chen, Yu. et. all. (2020). Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. CC-BY-NC-ND 4.0 International. https://doi.org/10.1101/2020.03.10.20033795

Damayanti, M., & Surati. (2020). Gambaran Kadar SGPT pada Pasien Tuberculosis Multidrug Resistant. Jurnal Laboratorium Medis, 02(02), 68–74. Retrieved from https://ejournal.poltekkes-smg.ac.id/ojs/index.php/JLM/%0A69

Damayanti, Hikmatul. & Budoyono C. (2021). Pengaruh Vitamin C, Vitamin D, dan Zinc Terhadap COVID-19. Jurnal Kedokteran Unram. https://doi.org/10.29303/jku.v10i4.597

Drew, Clement; Adisasmita, Asri C. (2021). Gejala dan komorbid yang memengaruhi mortalitas pasien positif COVID-19 di Jakarta Timur, Maret-September 2020. Tarumanagara Medical Journal. https://journal.untar.ac.id/index.php/tmj/article/view/11742

Fauzia, Nikma Syalsabiela. (2021). Faktor Risiko Terjadinya Coronavirus Disease 2019 pada Pasien dengan Komorbid Diabetes Melitus. Jurnal Ilmu Kesehatan. https://doi.org/10.37148/arteri.v2i4.177

Gunawan, Arif; dkk. (2020). Pengaruh komorbid hipertensi terhadap severitas pasien coronavirus disease 2019. Jurnal implementa husada. http://dx.doi.org/10.30596%2Fjih.v1i2.4972

Hasanah, Nurul. (2021). Analisis prevalensi komorbid dengan kematian pasien COVID – 19 di kabupaten bangkalan. Keperawatan stikes ngudia husada madura. http://repository.stikesnhm.ac.id/id/eprint/953/

Hikmawati, Isna. & Setiyabudi, Ragil. (2020). Hipertensi Dan Diabetes Militus Sebagai Penyakit Penyerta Utama Covid-19 Di Indonesia. Diakses melalui https://semnaslppm.ump.ac.id/index.php/semnaslppm/article/view/224/219

Kahar, F., Dirawan, G. D., Samad, S., Qomariyah, N., & Purlinda, D. E. (2020). The Epidemiology of COVID-19, Attitudes and Behaviors of the Community During the Covid Pandemic in Indonesia. International Journal of Innovative Science and Research Technology, 5(8), 1681–1687. https://doi.org/10.38124/ijisrt20aug670

Kahar, F., Purlinda, D. E., & Setyowatiningsih, L. (2022). Profil Diabetes Mellitus Pada Penderita Tuberculosis. Prosiding Seminar Nasional UNIMUS, 5, 1086–1095.

Kahar, F., Widarti, & Wikandari, R. J. (2022). Respondent Characteristics and Student Health Knowledge About Covid-19. Journal for ReAttach Therapy and Developmental Diversities, 5(1), 28–40.

Kahar, F., & Wikandari, R. J. (2022). Knowledge and COVID-19 prevention behavior : A case study of medical laboratory technology students in Indonesia. International Journal of Health Sciences, 6(S1), 7428–7442.

Masitah, I. N. (2022). Profil Mikroskopis BTA pada Sputum Keluarga Pasien Terdiagnosa BTA Positif Fase Lanjutan. Jaringan Laboratorium Medis, 04(01), 31–36.

Maciel, Ethel Leonor Noia, et. all. (2020). Tuberculosis and coronavirus: what do we know?. Epidemiol. Serv. Saude, Brasília. http://dx.doi.org/10.5123/s1679-49742020000200010

Maftuhah, Laelatul. (2021). Gambaran biaya langsung medis pada pasien COVID-19 dengan komorbid di instalasi rawat inap rsud provinsi ntb tahun 2020. Universitas Muhammadiyah Mataram. http://repository.ummat.ac.id/id/eprint/3976

Novitasari, P. A., Kahar, F., & Irnawati, I. (2022). Gambaran Kepositifan Basil Tahan Asam Pasien Diagnosis Klinis Tuberculosis Paru di Balai Kesehatan Masyarakat Semarang. Jurnal Laboratorium Medis, 04(02), 95–100. Retrieved from https://ejournal.poltekkes-smg.ac.id/ojs/index.php/JLM/

Satria, Raden., Tutupoho, R., & Chalidyanto, D. (2020). Analisis faktor risiko kematian dengan penyakit komorbid COVID-19. Jurnal Keperawatan Silampari, 4(1), 48-55. https://doi.org/https://doi.org/10.31539/jks. v4i1.1587

Suharyati, & Widiyanto, S. Y. D. (2019). Blood Glucose Levels in Patients with Lung Tuberculosis with Positive Acid Resistant Bacteria. JAringan Laboratorium Medis, 01(01), 42–45.

The TB/COVID-19 Global Study Group. (2021). Tuberculosis and COVID-19 co-infection: description of the global cohort. European Respiratory Society. DOI: 10.1183/13993003.02538-2021

Wulandari, Endang, W., Ronoatmodjo, S., Salama, N. (2021). Hubungan Komorbid Hipertensi dengan Kematian pada Kasus Konfirmasi COVID-19 di DKI Jakarta, Maret-Agustus 2020. Jurnal Ilmu Kesehatan Masyarakat. http://journals.stikim.ac.id/index.php/jikm

DOI: https://doi.org/10.31983/jlm.v5i2.9829

Article Metrics

Abstract view : 99

Download PDF : 91

Refbacks

There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

OFFICE INFORMATION :

Jurusan Analis Kesehatan - Kemenkes Poltekkes Semarang, https://analis.poltekkes-smg.ac.id Jl. Wolter Monginsidi No. 115 Pedurungan Tengah, Semarang, Jawa Tengah, Indonesia ; Telp./Fax: (024)6723014 Email: jlm@poltekkes-smg.ac.id

Jaringan Laboratorium Medis disseminated below Creative Commons Attribution-ShareAlike 4.0 International License.